ABIGAIL STRIKE: Open Payments
NPI 1063134997 · HERSHEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,414 in 57 payments from 26 companies in 2025. Trend: 2023 $1,364 · 2024 $2,467 · 2025 $1,414
Food & beverage: $1,314Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $145 |
| SOBI, INC | 2 | $123 |
| AstraZeneca Pharmaceuticals LP | 5 | $121 |
| Janssen Biotech, Inc. | 5 | $99 |
| E.R. Squibb & Sons, L.L.C. | 4 | $95 |
| Merck Sharp & Dohme LLC | 3 | $91 |
| GlaxoSmithKline, LLC. | 3 | $74 |
| Celgene Corporation | 3 | $69 |
| Gilead Sciences, Inc. | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $54 |
Products named: Enhertu, KEYTRUDA, SCEMBLIX, OJJAARA, OPDIVO, REBLOZYL, Trodelvy, TALVEY.
Industry payments across PA — which companies pay providers there.
